European Journal of Dermatology
The official journal of the European Dermatology Forum
The European Journal of Dermatology is an internationally renowned journal for dermatologists and scientists involved in clinical dermatology and skin biology.
Original articles on clinical dermatology, skin biology, immunology and cell biology are published, along with review articles, which offer readers a broader view of the available literature. Each issue also has an important correspondence section, which contains brief clinical and investigative reports and letters concerning articles previously published in the EJD.
The policy of the EJD is to bring together a large network of specialists from all over the world through a series of editorial offices in France, Germany, Italy, and Spain.
The European Journal of Dermatology is indexed in Medline and the Current Contents and the continually improving Impact Factor is evidence of its high quality and international recognition.
The online version of European Journal of Dermatology is now available to both readers and authors. All articles published since 1997 can now be accessed online by pay per view or by subscription.
Impact Factor 2020: 3.328
Instructions to Authors
The European Journal of Dermatology publishes reviews and original articles pertinent to skin diseases and to the structure and function of normal skin.
SUBMISSION SHOULD BE MADE online at: http://libbey.fontismedia.com/ejd/
Dr Jean KANITAKIS (France)
Dr Jean-François NICOLAS (France)
E-mail : email@example.com
Dr Ketty PERIS (Italy)
Dr Ana GIMENEZ-ARNAU (Spain)
Dr Gang Wang (China)
Submission. Submission of an article is understood to imply that the article is original and unpublished and not being considered for publication elsewhere. The responsible author must ensure that the article has been seen and approved by all the other authors. All articles are subject to peer review by one or more referees. Authors are invited to propose 3 potential reviewers with their e-mail addresses. All submissions are subject to a 50 € processing charge, to be paid during the submission process, via a secure page online. Authors of invited reviews, letters concerning articles previously published in the EJD and items to be published in the “Residents’ Corner” are not required to pay submission fees. Authors of such papers should contact the editorial office before submitting their article.
Copyright. Authors of papers accepted for publication grant John Libbey Eurotext an exclusive licence to publish, in return for which they can re-use their papers in their future printed work without first requiring permission from the publisher of the journal. Authors may archive this version of the manuscript in their institution’s repositories and, if they wish, on their personal websites. Authors should cite the publication reference on any deposited version, and provide a link from it to the URL of the published article on the journal’s website.
Ethics. When reporting experiments on human and animal subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human/animal experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as amended in 1983. If in doubt, the authors must explain the rationale for their approach and demonstrate that the institutional review board explicitly approved the doubtful aspects of the study.
Clinical Trial Registration. The European Journal of Dermatology subscribes to the standards set forth by the International Committee of Medical Journal Editors in the Lancet (364:911-912, 2004), requiring that all trials that start enrolling participants after July 1, 2005 must be registered in a suitable publicly accessible register in order to be considered for publication in the Journal.
Types of articles. The European Journal of Dermatology publishes articles in the following rubrics: Editorials, Review Articles, Investigative Reports, Genes and Skin, Therapy, Clinical Reports, Correspondence. Single case reports are normally only considered suitable for publication as correspondence items. Authors may propose the rubric for which they consider their article is most suitable, although the final decision will be taken by the Editor.
Correspondence includes brief clinical and investigative reports and letters commenting articles previously published in the journal. Correspondence items MUST be limited to a maximum of 700 words, one figure/table (the figure can be a mounted one) and ten references. No abstract/key words are needed. All correspondence items are subject to possible editing/abridgement.
Organisation of manuscripts. Every part of the manuscript should be numbered, beginning with the title page. Standard manuscripts should include: title page, abstract, introduction, materials and methods, results, discussion, acknowledgements, references, tables, legends for fi gures.
The Title page should contain (1) the full title, (2) a short title (3) full name(s) of the author(s), (4) complete postal address(es) of the affi liation(s) of the author(s), indicating the country in which the work was done, (5) an e-mail address to which proofs and reprint requests will be sent, plus telephone and fax numbers (6) the total number of words, figures, tables and references.
The Abstract should consist of no more than 250 words. Abstracts of Investigative Reports, Genes and Skin, Therapy and Clinical Reports should be structured (Background, Objectives, Materials & Methods, Results, Conclusion). Up to six key words should be provided in alphabetical order at the end of the abstract.
Materials and Methods should clearly and concisely describe all compounds and methods used so that these can be reproduced. A note on the statistical methods used to evaluate the results should also be included. The briefest form should always be chosen for all data presented.
Acknowledgements. In this section the authors must declare:
Financial support from the pharmaceutical industry or any other source. Grants and research contracts must indicate the name of the person or unit which received aid. If there has been no financial support, write NONE.
Conflict of Interest. It is the responsibility of the corresponding author to ensure that any conflict of interest of any of the authors is disclosed. A declaration must be made, if there is no conflict of interest, write NONE.
References. Their number should be kept to the minimum necessary to support the data and discussion; extensive lists of references should be avoided. Number the references consecutively as they appear in the text. List all authors if six or less, otherwise list the first three authors followed by “et al”. References concerning unpublished data and ‘personal communications’ should be cited parenthetically within the text but not in the list of references. Abbreviate journal names according to the listing in Index Medicus.
Barbaud A, Granel F, Waton J, Poreaux C. How to manage hypersensitivity reactions to biological agents? Eur J Dermatol 2011; 21: 667-74.
Advance online publication of a journal article:
Morelon E, Kanitakis J, Petruzzo P. Immunological issues in clinical composite tissue allotransplantation: where do we stand today? Transplantation 2012 Feb 2. doi: 10.1097/TP.0b013e31824728b8 [Epub ahead of print]
Weedon D. Skin Pathology. 3rd edn. Philadelphia: Churchill Livingstone, 2010.
Chapter in a Book:
Gawkrodger DJ. Sarcoidosis. In: Burns T, Breathnach S, Cox N, Griffi ths C, eds. Rook’s Textbook of Dermatology. 8th edn. Oxford: Wiley-Blackwell Scientifi c Publications, 2010: 61.1-61.23.
U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2007 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2010. Available at: www.cdc.gov/uscs (accessed 04 Feb 2012).
Figures and diagrams should be referred to in the text as “Fig.” and be given arabic numbers. The magnification should be indicated directly on the figure using a bar and including the corresponding measurement in the legend. The graphic files must be saved as .JPEG. All figures and diagrams must be accompanied by a legend. All type within the figures should be at least size 9, using the following fonts: Helvetica, Arial, Times, Courier, Symbol. Line art should have a resolution of approximately 1,000 dpi. Half-tone graphics (photographs or graphics with shades of grey) should have a resolution of 300 dpi. A figure that is a combination of both a half-tone and line art must have a resolution of at least 500 dpi. Patients should have their identity concealed or should give written consent to publication. In the event that some of the illustrations are owned by third parties, the author undertakes to obtain the necessary permission from the latter to include the illustrations in the article and the distribution thereof in this form. The manuscript must be accompanied by written permission for publication. These permissions are generally granted via the https://www.copyright.com website (see "Get permission" button available for each article).
Tables should be drawn in black ink on a white background. Lines should be of sufficient thickness to withstand reduction. There should be as few tables as possible and these should include essential data only.
Units, symbols, abbreviations. Measurements should be in metric units (meter, kilogramme, liter) or their decimal multiples. Temperature should be given in °C. Abbreviations should be used sparingly and always given in full at the first mention.
Proof corrections are limited to typographical errors. One set of page proofs will be sent by email to the corresponding author who should return the corrected proofs within two days of receipt. The copyright form will accompany the proofs and must be returned with the corrected proofs. Following publication, a .pdf copy of the article will be sent to the corresponding author for personal use only.
Announcements. Brief announcements of scientific meetings will be published at the discretion of the Editor, if space permits. Announcements must reach the editorial office at least 10 weeks before the publication date.
Page charges. All corresponding authors of accepted articles (except for invited articles, letters concerning articles previously published in the EJD and submissions to Residents’ Corner) will be asked to pay page charges of 200 €. Please note, there is no charge for colour illustrations. An invoice will be sent to the corresponding author of accepted articles at the same time as the proofs and copyright transfer form. Authors may ask to have their articles freely available in the online version of the journal (open access); this will be charged at an extra 900 €.
Residents’ corner is dedicated to Dermatology residents and is a place where residents have the opportunity to voice their opinions. Selected editorials and clinical quiz items (sQUIZ your knowledge!) can be published, according to the following guidelines. All contributions should be submitted online at http://libbey.fontismedia.com/ejd/ as correspondence. Authors should add “RC” at the beginning of the title when submitting. A covering letter is mandatory and must be addressed to the coordinator of the resident board, indicating which type of contribution has been chosen (“Editorial” or “sQUIZ your knowledge!”).
Items to be published in the "Residents’ Corner" are not required topay submission fees. Authors of such papers should contact the editorial office before submitting their article.
- The subject must deal with topics concerning the whole community of Dermatology residents.
- The rubric may include one picture (jpeg format) and maximum 1000 characters (approximately 130 words) including blank spaces (the author(s) and name(s) of institution(s) and references are not included in the character count).
- One or 2 authors maximum can be accepted.
“sQUIZ your knowledge!” guidelines:
- The subject must cover major topics in general dermatology,as well as focusing on the subspecialty areas of dermatopathology, dermatologic surgery and pediatric dermatology. Clinical cases, or articles regarding dermatological therapeutics may be submitted.
- The rubric must include one picture or one mounted picture(jpegformat) and a maximum of 1000 (approx. 130 words) for clinical cases or 2000 characters (approx. 300 words) for contributions focusing on therapeutics, including blank spaces (the author(s) and name(s) of institution(s) and references are not included in the character count).
- The picture can be accompanied by a short sentence containing clinical information.The answer and a short explicative text will be published in the following issue.
- Two or 3 authors maximum can be accepted (the first two should be mandatorily medical residents in Dermatology).